Skip to content

About Us
Contact Us
News & Events

AIR Technology
ZIVA™ Platform
Fixed Assays
Custom Assays
Resources
- Publications and Downloads
- COVID-19 Research

AIR Technology
ZIVA™ Platform
Fixed Assays
Custom Assays
Resources
- Publications and Downloads
- COVID-19 Research

Previous

Next

St. Louis Post-Dispatch: As Adarza scales up, St. Louis hopes for an important win

As Adarza scales up, St. Louis hopes for an important win. By D avid Nicklaus

READ MORE

Using lasers to paint a high-definition picture of the body’s COVID-19 immune response

August 14, 2020

Adarza Shifts Focus to SARS-CoV-2 in Anticipation of Protein Biosensor Launch

August 14, 2020

Adarza’s Ziva provides window into immune response to COVID-19 and other pathogens

June 24, 2020

St. Louis biotech startup raises $25M as it prepares for commercialization

February 6, 2020

Adarza raises $25 million, moves toward commercialization

February 5, 2020

Adarza BioSystems Raises $25 Million in Series D Funding to Launch Platform for Research and Drug Development

February 4, 2020

NAVIGATE

AIR Technology
ZIVA Platform
Custom Assays
Publications and Downloads
COVID-19 Research
Contact Us

Menu

AIR Technology
ZIVA Platform
Custom Assays
Publications and Downloads
COVID-19 Research
Contact Us

READ THE LATEST

Using lasers to paint a high-definition picture of the body’s COVID-19 immune response

Adarza Shifts Focus to SARS-CoV-2 in Anticipation of Protein Biosensor Launch

Adarza’s Ziva provides window into immune response to COVID-19 and other pathogens

JOIN OUR LIST

First Name *

Last Name *

Email *

Company

Comment

Copyright © 2021 Adarza BioSystems
All Rights Reserved | ADARZA BIOSYSTEMS is a registered trademark of Adarza Biosystems, Inc.